PPA stands for postpartum anxiety, and PPD stands for postpartum depression. Both are mood disorders that develop after giving birth, and they’re roughly equally common. While most new parents experience mild mood shifts in the first week or two (often called the “baby blues”), PPA and PPD are more intense, longer lasting, and can significantly interfere with daily life and bonding with your baby. They can also occur together.
How PPD and PPA Feel Different
PPD and PPA share some overlap, but their core experiences are distinct. PPD centers on low mood: persistent sadness, hopelessness, feeling overwhelmed, and losing interest in things you used to enjoy. You might feel disconnected from your baby, struggle with guilt or worthlessness, lack energy and motivation, or have difficulty concentrating and making decisions. In severe cases, thoughts of self-harm can occur.
PPA, by contrast, centers on worry and hypervigilance. The hallmark is excessive, uncontrollable worry about a range of things: your baby’s health, your ability as a parent, finances, safety. You might feel restless, on edge, or irritable much of the time. Physical symptoms are common too, including muscle tension, stomach problems, and a racing heart. Concentration suffers, but for a different reason than with depression. Rather than mental fog from low energy, your mind feels like it won’t stop spinning.
Some parents experience both simultaneously. If you’re constantly anxious about your baby’s wellbeing while also feeling emotionally flat and disconnected, that combination of PPA and PPD is not unusual.
When Symptoms Typically Start
Symptoms can begin during pregnancy or within the first weeks after delivery. The DSM-5-TR (the standard diagnostic manual) applies a “peripartum onset” label when a major depressive episode starts during pregnancy or within four weeks of delivery, but most experts recognize that symptoms can first appear anytime within the first 12 months postpartum.
A diagnosis of perinatal depression requires at least five depressive symptoms lasting at least two weeks. PPA doesn’t have its own formal diagnostic category in the DSM-5-TR, which is one reason it often goes unrecognized, but clinicians screen for it using anxiety-specific tools alongside depression questionnaires.
How Long It Can Last
Without treatment, PPD can persist far longer than many people expect. A large NIH-funded study tracking over 4,500 women for three years after birth found four distinct patterns. About 75% of participants had consistently low symptoms. Roughly 13% had moderate symptoms that gradually improved on their own. But 8% started with low symptoms that actually worsened over time, and about 5% experienced high levels of depressive symptoms that persisted for the full three years of the study.
Current guidelines recommend screening mothers for postpartum depression for up to six months after birth, but these findings suggest that window may be too short for a meaningful number of women.
What Causes These Conditions
The hormonal shift after delivery is a major biological trigger. During pregnancy, levels of estrogen and progesterone rise dramatically. After birth, both hormones plunge. That drop in progesterone is directly linked to depressive symptoms. Estrogen, meanwhile, normally helps the brain produce and use serotonin (a chemical tied to mood regulation). When estrogen falls postpartum, that natural mood-stabilizing effect disappears.
These hormonal swings create what researchers describe as a “vulnerable terrain” for mood disorders. But biology alone doesn’t determine who develops PPA or PPD. A personal or family history of depression or anxiety, stressful life events, lack of social support, sleep deprivation, and complications during pregnancy or delivery all raise risk. The conditions likely result from hormonal vulnerability colliding with environmental and psychological stress.
Effects on Your Baby
Untreated PPD doesn’t just affect the parent. A systematic review of maternal and infant outcomes found that maternal depression negatively impacted mother-to-infant bonding across 11 separate studies. At nine months old, infants of mothers with depression showed the lowest social engagement, less mature self-regulation, and more negative emotionality compared to other babies.
The effects extend into development. After adjusting for other variables, maternal depression placed children at roughly six times the risk of delayed emotional development. Multiple studies also found negative associations with infant cognitive development, language development, and sleep quality. These findings aren’t meant to create guilt. They’re a reason to take these conditions seriously and seek support early.
How Screening Works
The most widely used screening tool is the Edinburgh Postnatal Depression Scale (EPDS), a 10-question self-report questionnaire. Scores of 12 or higher are strongly associated with major or minor depressive symptoms and typically prompt further clinical evaluation. The EPDS is a screening tool, not a diagnosis on its own, but it’s a reliable first step. Your OB, midwife, or your baby’s pediatrician may offer it at postpartum or well-child visits.
Because PPA can exist without depression, and the EPDS focuses primarily on depressive symptoms, some providers also use anxiety-specific screening tools. If your main struggles are racing thoughts, constant worry, and physical tension rather than sadness, mention those symptoms specifically.
Treatment Options
Both PPA and PPD respond well to treatment. The two main approaches are therapy and medication, used alone or together.
Cognitive behavioral therapy (CBT), which helps you identify and reframe unhelpful thought patterns, has strong evidence for both conditions. One study found a specialized CBT program designed for postpartum depression was more effective as a standalone treatment than antidepressant medication alone. Many parents prefer therapy over medication, particularly if they’re breastfeeding, and research supports it as a first-line option for mild to moderate symptoms.
For moderate to severe PPD, SSRIs (a class of antidepressant that increases serotonin activity in the brain) are the most commonly prescribed medications. These are the same antidepressants used for depression outside of the postpartum period, and treatment courses typically last 12 weeks or longer.
A Newer, Faster-Acting Option
In 2023, the FDA approved zuranolone (brand name Zurzuvae), the first oral medication designed specifically for postpartum depression. Unlike traditional antidepressants that take weeks to build up, zuranolone is a 14-day course: one pill taken each evening with food. It works by mimicking a natural brain chemical called allopregnanolone, which drops after delivery and plays a role in mood regulation.
In two large clinical trials, women taking zuranolone showed roughly four points more improvement on a standard depression scale compared to placebo by day 15. It can be used on its own or alongside a traditional antidepressant. An earlier IV-administered version of the same approach (brexanolone) was approved in 2019 but requires a 60-hour hospital infusion, making the oral pill a far more practical option for most people.
PPA and PPD Can Overlap
It’s worth emphasizing that these two conditions frequently coexist. You might feel consumed by worry about your baby while simultaneously losing interest in activities, struggling to eat, or feeling persistently sad. If your experience doesn’t fit neatly into one category, that’s normal. The labels matter less than recognizing that what you’re going through is a treatable medical condition rooted in real biological and psychological changes, not a reflection of your ability as a parent.